1 Arrested With Banned Drugs Worth Rs 5.22 Lakh From Valsad, Gujarat

Mira Bhayandar: Just under a month following the arrest of an individual caught with restricted drugs valued at Rs. 3.66 lakh in Kashimira, the Anti-Narcotics Cell (ANC) of the Mira Bhayandar-Vasai Virar (MBVV) police successfully traced the origin of the contraband to a commercial establishment situated in Valsad city, Gujarat, on Friday.

On September 18th, the ANC had apprehended a Mira Road resident found in possession of restricted drugs, including 300 bottles of cough syrup containing codeine phosphate and 10,800 tablets of Alprazolam. In the course of their investigations to determine the source of the contraband, the ANC managed to acquire a mobile number allegedly used by one of the suspects to communicate with buyers. Utilizing call data records and technical surveillance, the police located the accused’s phone to be active within the tower limits of Sethia Nagar in Valsad.

Promptly, ANC personnel led by PSI Santosh Ghadge rushed to Valsad and apprehended the accused. Subsequent intensive interrogations led the accused to disclose a larger consignment valued at over Rs. 5.22 lakh. This included 969 bottles of cough syrup containing codeine phosphate and 1,930 tablets of Alprazolam, both classified as scheduled drugs. The misuse and illegal sale of these drugs as narcotics are punishable under the provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Act of 1985.

Notably, stringent regulations govern the sale and purchase of such cough syrups, which are recognized as potent intoxicants. Nonetheless, numerous drug addicts consume these syrups to achieve a high. Moreover, unregistered suppliers allegedly distribute cough syrups and tablets to chemists who reportedly sell them at prices exceeding the maximum retail price, often without requiring the mandated prescription from a registered medical practitioner, according to sources.

Related Posts

  • Pharma
  • July 26, 2024
  • 111 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 105 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD